tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nicole Germino, 19 are a BUY (82.61%), 4 are a HOLD (17.39%).
Analyst Nicole Germino, currently employed at TRUIST, carries an average stock price target met ratio of 61.11% that have a potential upside of 64.04% achieved within 205 days.
Nicole Germino’s has documented 42 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 20-Feb-2025.
Analyst best performing recommendations are on FBRX (FORTE BIOSCIENCES).
The best stock recommendation documented was for FBRX (FORTE BIOSCIENCES) at 9/3/2021. The price target of $100 was fulfilled within 11 days with a profit of $26.5 (20.95%) receiving and performance score of 19.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$39
$15.68 (67.24%)
$31
27 days ago
(07-Sep-2025)
0/2 (0%)
$15.68 (67.24%)
Hold
6 months 11 days ago
(23-Mar-2025)
0/1 (0%)
$-9.98 (-79.97%)
Buy
$14
$-9.32 (-39.97%)
$14
2 years 10 months 19 days ago
(15-Nov-2022)
4/4 (100%)
$-1.84 (-11.62%)
328
Buy
$11
$-12.32 (-52.83%)
$12
2 years 11 months 11 days ago
(23-Oct-2022)
5/5 (100%)
$-8.2 (-42.71%)
307
Buy
$12
$-11.32 (-48.54%)
$15
3 years 6 months 4 days ago
(31-Mar-2022)
2/2 (100%)
$-12.72 (-51.46%)
502
What Year was the first public recommendation made by Nicole Germino?
